Company profile: Coriell Life Sciences
1.1 - Company Overview
Company description
- Provider of precision medicine solutions using pharmacogenomics, bioinformatics, and clinical decision support software. Offers turnkey genetic interpretation, reporting, and medication risk management for payers, pharmacists, providers, and patients. Products include Corigen Medication Safety Program, Pharmacogenomic Research Analysis Services, Return-to-Operations Program, GeneDose, and GeneDose LIVE.
Products and services
- GeneDose LIVE: A real-time tool that models drug regimens using patient genetics, demographics, lifestyle, and medical conditions to minimize risks while achieving therapeutic goals, supporting individualized pharmacotherapy
- GeneDose: A polypharmacy-focused report delivering medication recommendations and risk insights derived from genetic testing, optimizing medication safety and efficacy for complex regimens through comprehensive analysis
- Corigen Medication Safety Program: A DNA-based program that improves medication efficacy by eliminating trial-and-error prescribing, using genetic testing insights to reduce risks and healthcare costs.
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Coriell Life Sciences
CareFacts
HQ: United States
Website
- Description: Provider of data entry, point-of-care clinical documentation, billing, and scheduling software for home care, hospice, and public health agencies.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full CareFacts company profile →
OncoLens
HQ: United States
Website
- Description: Provider of oncology care coordination and collaboration software that replaces labor‑intensive patient case collaboration and supports CoC accreditation. Solutions include OncoLens Conference for automated data collection and accreditation reporting; Collaborate for secure, real-time case collaboration; Integrate for EMR and lab data integration; Secure SSO; Image Share; and Analyze and Patient Finder for AI-driven trial identification and quality improvement reporting.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full OncoLens company profile →
Random42
HQ: United Kingdom
Website
- Description: Provider of scientific digital solutions for the pharmaceutical and biotech industry, delivering medical animation, virtual reality, augmented reality, mixed reality, and interactive experiences that simplify complex medical and scientific concepts and enable immersive understanding and engagement.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Random42 company profile →
Pearl Health
HQ: United States
Website
- Description: Provider of an integrated platform for primary care providers, delivering data-driven insights and suggestions to keep patients healthy. Offerings include predictive analytics prioritizing patients and conditions needing attention (Actionable Insights), streamlined access to patient data from various sources (Simple Visibility), a Value-Based Care Advisor Tool, Transitional Care Management, and resources on direct contracting and value-based care.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Pearl Health company profile →
Ocuco
HQ: Ireland
Website
- Description: Provider of off-the-shelf software and services for the optical industry, offering Acuitas EHR and practice management for eyecare, Innovations lab management integrating all lab operations and online retailers, plus digital marketing, e-commerce integration via eCommConnect, and eLearning with 160+ interactive courses for independent opticians, optical retail chains, and lens manufacturing labs.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Ocuco company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Coriell Life Sciences
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Coriell Life Sciences
2.2 - Growth funds investing in similar companies to Coriell Life Sciences
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Coriell Life Sciences
4.2 - Public trading comparable groups for Coriell Life Sciences
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →